33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135689
178559
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Receber premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcordoPrivacidadeFAQ
Support 24/7  
CabinetGet premium
Donate

6 ago 2018 ano - FDA issued the draft guidance for industry, “Opioid Use Disorder: Endpoints for Demonstrating Effectiveness of Drugs for Medication-Assisted Treatment,” which is intended to assist sponsors in developing drugs for medication-assisted treatment of opioid use disorder (OUD) and addresses the clinical endpoints acceptable to demonstrate effectiveness of such drugs.

Adicionado na linha do tempo:

Opioids and the FDA

ByAnastasia
13 nov 2018
0
0
521

Data:

6 ago 2018 ano
Agora
~ 7 years and 2 months ago
About & FeedbackAcordoPrivacidadeFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL